A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors
BioNTech SE
BioNTech SE
Eli Lilly and Company
National Cancer Institute (NCI)
Context Therapeutics Inc.
OncoC4, Inc.
Compass Therapeutics
Agenus Inc.
GlaxoSmithKline
SystImmune Inc.
Xencor, Inc.
Atavistik Bio, Inc
Alterome Therapeutics, Inc.
BeOne Medicines
Myeloid Therapeutics
Tizona Therapeutics, Inc
IDEAYA Biosciences
MacroGenics
Doma Biopharmaceutical(Suzhou)Co., Ltd.
M.D. Anderson Cancer Center
Dren Bio
Sairopa B.V.
NeoTX Therapeutics Ltd.
West China Hospital
Incyte Corporation
Tempest Therapeutics
Pfizer
Exelixis
Numab Therapeutics AG
Totus Medicines
NextPoint Therapeutics, Inc.
Pfizer
Black Diamond Therapeutics, Inc.
Theratechnologies
Seagen Inc.
Checkpoint Therapeutics, Inc.
Astellas Pharma Inc
Carisma Therapeutics Inc
Acepodia Biotech, Inc.
Vincerx Pharma, Inc.
Danatlas Pharmaceuticals Co., Ltd
Brown University
Xencor, Inc.
Pliant Therapeutics, Inc.
Arcus Biosciences, Inc.
Haihe Biopharma Co., Ltd.
Celon Pharma SA
Corvus Pharmaceuticals, Inc.
QuantumLeap Healthcare Collaborative
Fate Therapeutics
Xencor, Inc.